Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
about
Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinomaMethylation-mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinomaA new model for raf kinase inhibitory protein induced chemotherapeutic resistanceMalignant ovarian tumors with induced expression of carbonyl reductase show spontaneous regression.Carbonyl Reductase 3 (CBR3) Mediates 9-cis-Retinoic Acid-Induced Cytostatis and is a Potential Prognostic Marker for Oral Malignancy.Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer.Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma.Genetic and immunohistochemical characterization of Epstein-Barr virus-associated diffuse large B-cell lymphoma.The role of carbonyl reductase 1 in drug discovery and development.Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse models.RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma.Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo.Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma.Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinoma.Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.Decreased carbonyl reductase 1 expression promotes tumor growth via epithelial mesenchymal transition in uterine cervical squamous cell carcinomas.
P2860
Q24656802-387A1B82-7C9C-47D9-8FF1-3F226F18C681Q24656802-7C823C03-E592-4FB7-B4C7-512FAC1D9806Q28289569-E1B1560B-4131-4934-9FCC-0010894E8EF8Q28478945-616B2C81-68E4-4942-9A19-91F103601CBEQ28478945-6F3719AC-2C26-4567-8837-9CB68839E04EQ35789665-1AA8D0F3-FA34-49EE-B6A0-A292F06031FBQ35789665-3BC02FB6-3A80-44D6-9C66-AC9B2D4487C5Q36968288-41FEB7F5-8C8D-4DCD-A2DA-E6769C90CAA9Q36968288-B31AF18F-FA6C-4BC3-8529-D5D54E0C7FDBQ37486164-0E0BACD6-0330-4226-AB5C-19E0EBA4752BQ37486164-3C64C23D-5854-4327-9544-892333EB7196Q37579010-858C72B1-241D-4B22-88B4-20C999656E50Q37579010-B61DC033-6C50-44C3-A17C-3E7108F8511EQ38321663-791A8202-029A-4CFC-80C1-EE5FE22E294FQ38395037-48BBDDD6-81A4-4B58-97B2-BC12E1E44DF1Q38656979-8A921C23-AA2C-4497-8F13-1C6B1D84EFDEQ38818448-82C5247E-7044-43F5-A5D5-E00CB4995C8DQ38920937-E1E70C08-6EA9-4BED-9C56-2CDED8992157Q38998339-BCDA4C04-C9FB-4E74-802E-571FCDEBD34BQ39001875-86307198-F715-4826-B709-505A16A3EE08Q39136151-3867CA6A-9ECC-4EB4-AD55-316E60B67A0CQ39368597-D95F7DF4-DC1F-4098-9AB0-AA141A6707A3Q39522931-EBC283F9-5F94-47D1-8EB1-E0BF4CC34212Q41202043-13A2D05F-B46C-422F-9FAD-9BACDE205202Q49873985-B6231175-4711-4CB1-A959-ACF18D0C6EA5Q49873985-DF22C40D-4C2A-4276-9748-9E746C99D755Q51162288-5FD0EF84-EA58-449D-8BAA-D9745327E98CQ53315728-6CE5E44D-53F9-432D-B513-8A65271D6EC8Q55002082-64D1EEF8-2107-4424-8847-61D34E23A3ABQ55002082-C4605D4B-4E27-4273-ABA0-1128B6FA50AD
P2860
Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@ast
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@en
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@nl
type
label
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@ast
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@en
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@nl
prefLabel
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@ast
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@en
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@nl
P2093
P2860
P577
P921
P1476
Carbonyl reductase as a signif ...... s in epithelial ovarian cancer
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6692034
10.1054/BJOC.2001.2034
P407
P577
2001-09-01T00:00:00Z
2001-09-28T00:00:00Z
2001-10-05T00:00:00Z
P5875
P6179
1003010177